Bovine lactoferrin inhibits influenza A virus induced programmed cell death in vitro

Agostina Pietrantoni1, Eleonora Dofrelli, Antonella Tinari

  • 1Department of Technology and Health, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy.

Insights

Bovine lactoferrin (bLf) combats Influenza A virus by inhibiting apoptosis and blocking viral assembly. This research reveals bLf

Area of Science:

  • Virology
  • Immunology
  • Biochemistry

Background:

  • Influenza poses a significant global health threat, exacerbated by antiviral resistance.
  • Lactoferrin exhibits antimicrobial and immunomodulatory properties, with potential antiviral applications.
  • The precise antiviral mechanism of lactoferrin remains incompletely understood.

Purpose of the Study:

  • To investigate the in vitro antiviral effects of bovine lactoferrin (bLf) against Influenza A virus.
  • To elucidate the molecular mechanisms underlying bLf's antiviral activity.

Main Methods:

  • In vitro study of Influenza A virus-infected cells.
  • Assessment of apoptosis induction and inhibition.
  • Analysis of caspase 3 activity.
  • Evaluation of viral ribonucleoprotein nuclear export.

Main Results:

  • Influenza A virus infection induced apoptosis in host cells.
  • bLf treatment inhibited virus-induced apoptosis by interfering with caspase 3.
  • bLf effectively blocked the nuclear export of viral ribonucleoproteins, hindering viral assembly.

Conclusions:

  • Bovine lactoferrin demonstrates significant antiviral activity against Influenza A virus in vitro.
  • bLf inhibits viral replication by preventing apoptosis and blocking viral assembly.
  • These findings suggest bLf as a potential therapeutic agent for influenza treatment.

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...